Bone Medical completes merger with Revenir

By Melissa Trudinger
Monday, 23 August, 2004

UK biotech company Bone Limited has completed its merger with Perth-based listed property management company Revenir (ASX: REV) after a successful capital raising of $2.5 million closed oversubscribed earlier in the month.

The company, which will be known as Bone Medical, is expected to start trading on August 31, 2004 under the stock symbol BNE.

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...

Content from other channels on our network

Australian health care's burnout prescription

"Fake podiatrist" jailed after hundreds of consultations with vulnerable patients

Unlocking the potential of our nursing workforce

National Model for Clinical Governance now available

SEKO IoT solutions revolutionise on-premise laundry dosing

How to extend the life of your motor bearings

Mars Petcare Wodonga expansion boosts manufacturing output

From Dark Age to Imperial: what Age of Empires teaches us about instrumentation

WA Government to boost development of Collie green steel mill

Queensland increases investment in CopperString

The potential of AI technologies across the food supply chain

Larry Emdur's whisky brand appoints CEO

Fonterra's leadership changes confirmed

Driving food safety through digital traceability and transparency

Mars expands local pet food production with new $112.6m facility now open